C - Chemistry – Metallurgy – 07 – C
Patent
C - Chemistry, Metallurgy
07
C
260/606.5, 260/6
C07C 211/21 (2006.01)
Patent
CA 1172266
ABSTRACT OF THE DISCLOSURE New nonaprenylamine derivatives having the general formula: Image (I) wherein R1 represents a hydrogen atom, a nonaprenyl group or a lower alkyl group, and R2 represents a lower alkyl or alkenyl group optionally substituted with at least one hydroxy or alkylamino group, or a cycloalkyl group, and the pharmaceutically acceptable acid addition salts thereof, are prepared by (a) converting nonaprenol of the formula: Image (II) into a corresponding halide or arylsulfonic acid ester which is thereafter reacted with a primary or secondary amino corn- pound having the general formula: Image (III) wherein R1 and R2 have the aforesaid meanings, in the presence or absence of a base, to obtain the desired nonaprenylamine of the formula (I), or (b) oxidizing nonaprenol to a corre- sponding aldehyde which is then condensed with a primary amino compound having the general formula: H2N-R2 (III') wherein R2 has the aforesaid meanings, to form a corresponding imino compound which in turn is reduced to obtain a nonaprenyl- amine of the formula (I) in which R1 is hydrogen and R2 has the aforesaid meanings. When a pharmaceutically acceptable acid addition salt is desired, the nonaprenylamine of the formula (I) thus obtained is further reacted with a pharma- ceutically acceptable acid to provide the desired salt. The nonaprenylamine derivatives of the formula (I) are useful for controlling virus infection of vertebrate animals.
376069
Komatsu Yasuhiro
Koyama Hiroyasu
Kubota Reiko
Tahara Yoshiyuki
Takahashi Toshihiro
Nisshin Flour Milling Co. Ltd.
Swabey Ogilvy Renault
LandOfFree
Nonaprenylamine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nonaprenylamine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nonaprenylamine derivatives will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1245771